Projects

« zurück zur Übersicht

Abionic
EPFL - Ecole Polytechnique Fédérale de Lausanne
Nicolas Durand

Based on an innovative nanotechnology approach, Abionic will develop and provide fast and low-cost screening tests for portable medical diagnostic use.

Based on an innovative nanotechnology approach, Abionic will develop and provide fast and low-cost screening tests for portable medical diagnostic use. As there are currently over 100 million people in Europe suffering from allergies, Abionic will firstly develop a novel personalized allergy diagnostic test that will allow patients to take the optimal medication.

Dokumente

Beschreibung
entrepreneurial ID
 

Multimedia

Videos, Slides & more

 

Bookmark and Share

People

Nicolas Durand (CEO/Chairman)

Unterstützung

venture kick

Mehr Startups in den Kategorien

Life Sciences
Diagnostics

Office

Abionic
BM3118 (Bâtiment BM)
1004 Lausanne